|[October 28, 2013]
Pathway Genomics Receives New York State Clinical Laboratory Permit
SAN DIEGO --(Business Wire)--
Genomics Corporation, a San Diego-based CAP-accredited clinical
laboratory that offers genetic testing services worldwide, today
announced it has received a Clinical Laboratory Permit from the New York
State Department of Health. The permit allows authorized health care
providers in the state of New York the ability to offer their patients Pathway
Fit®, the company's diet, metabolism, and exercise genetic test.
Considered one of the most rigorous control standards in the country,
the validation process required for a New York State Clinical Laboratory
Permit is designed to ensure reliable, accurate clinical laboratory
services. "Obtaining a New York State Clinical Laboratory Permit is an
exciting benchmark in Pathway's growth and a testament to the quality,
reliability and accuracy of Pathway's services," said David Becker,
Ph.D., Pathway Genomics' chief scientific officer.
Fit analyzes genes associated with food metabolism and exercise
response, and it provides actionable recommendations that aim to help
people maintain a healthy weight - and lose unhealthy weight - by
tailoring their diet and exercise plans to their genetics.
The only test of its kind available in New York, Pathway
Fit provides physicians and patients wit a critical new tool to
help combat rising obesity rates. According
to the CDC, 60 percent of New York's adults 18 years old and over
are overweight, and approximately 24 percent are obese. Additionally,
York State Department of Health reports that one-third of school-age
children in New York State - not including New York City - are
overweight or obese.
"Bringing Pathway Fit to the physicians and residents of the state of
New York is a vital objective in our mission to serve a broader patient
base," said Michael Nova (News - Alert), M.D., Pathway Genomics' chief medical officer.
"We feel that Pathway Fit will be a major and necessary catalyst for
behavioral change in the lives of many people living in New York."
About Pathway Genomics Corporation
As a CAP-accredited and CLIA-certified clinical laboratory based in San
Diego, California, Pathway
Genomics provides physicians and their patients with actionable and
accurate genetic information to improve or maintain health and wellness.
Since its founding in 2008, Pathway
Genomics has become known for its dedication to innovation and
commitment to medical responsibility - making it a leader in the
commercial genetic testing industry. Pathway
Genomics' testing services cover a variety of conditions including cardiac
health, cancer risk, inherited
and exercise response, as well as drug response for specific
medications including those used in pain
management and mental
health. For more about Pathway Genomics, visit www.pathway.com.
[ Back To Technology News's Homepage ]